• Register
X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X

Leaving Community

Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.

No
Yes

Progressive ataxia, myoclonic epilepsy and cerebellar apoptosis in cystatin B-deficient mice.

Loss-of-function mutations in the gene (CSTB) encoding human cystatin B, a widely expressed cysteine protease inhibitor, are responsible for a severe neurological disorder known as Unverricht-Lundborg disease (EPM1). The primary cellular events and mechanisms underlying the disease are unknown. We found that mice lacking cystatin B develop myoclonic seizures and ataxia, similar to symptoms seen in the human disease. The principal cytopathology appears to be a loss of cerebellar granule cells, which frequently display condensed nuclei, fragmented DNA and other cellular changes characteristic of apoptosis. This mouse model of EPM1 provides evidence that cystatin B, a non-caspase cysteine protease inhibitor, has a role in preventing cerebellar apoptosis.

Pubmed ID: 9806543

Authors

  • Pennacchio LA
  • Bouley DM
  • Higgins KM
  • Scott MP
  • Noebels JL
  • Myers RM

Journal

Nature genetics

Publication Data

November 16, 1998

Associated Grants

  • Agency: NICHD NIH HHS, Id: HD24064
  • Agency: NINDS NIH HHS, Id: NS29709

Mesh Terms

  • Amino Acid Sequence
  • Animals
  • Apoptosis
  • Ataxia
  • Base Sequence
  • Cerebellum
  • Corneal Opacity
  • Cystatin B
  • Cystatins
  • Cysteine Proteinase Inhibitors
  • DNA Primers
  • Disease Models, Animal
  • Epilepsies, Myoclonic
  • Female
  • Humans
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Mice, Inbred CBA
  • Mice, Knockout
  • Models, Genetic
  • Mutation
  • Phenotype